Success Metrics

Clinical Success Rate
95.0%

Based on 19 completed trials

Completion Rate
95%(19/20)
Active Trials
1(4%)
Results Posted
21%(4 trials)
Terminated
1(4%)

Phase Distribution

Ph phase_1
5
18%
Ph phase_3
2
7%
Ph not_applicable
14
50%

Phase Distribution

5

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution21 total trials
Phase 1Safety & dosage
5(23.8%)
Phase 3Large-scale testing
2(9.5%)
N/ANon-phased studies
14(66.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

95.0%

19 of 20 finished

Non-Completion Rate

5.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

28

all time

Status Distribution
Active(1)
Completed(19)
Terminated(1)
Other(7)

Detailed Status

Completed19
unknown7
Terminated1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
28
Active
1
Success Rate
95.0%
Most Advanced
Phase 3

Trials by Phase

Phase 15 (23.8%)
Phase 32 (9.5%)
N/A14 (66.7%)

Trials by Status

completed1968%
terminated14%
recruiting14%
unknown725%

Recent Activity

Clinical Trials (28)

Showing 20 of 28 trialsScroll for more
NCT07439276Not Applicable

Characterization of Social Cognition Profiles in Children and Adolescents With Neurodevelopmental Disorders: a Clinical Study Using a Multidimensional Battery

Recruiting
NCT06010355Not Applicable

Culturally Tailored Educational Video to Promote Lung Cancer Screening in Vulnerable Communities

Terminated
NCT05867862Not Applicable

Implementation of a Program to Strengthen Oral Hygiene in Patient With Cleft Deformities

Completed
NCT07150078

Dual Task and Attention Deficit and Hyperactivity Disorder

Completed
NCT03241511Not Applicable

Novel PAradigm to Improve Inflammatory Burden in ESRD (rePAIR): A Pilot and Feasibility Randomized Controlled Trial

Completed
NCT06003465Phase 1

A Research Study Looking at Similarity Between LY3437943 Versions for Different Injection Devices

Completed
NCT06300866Phase 3

Gingivitis Reduction After Use of 0.45% Stannous Fluoride Toothpaste

Completed
NCT05838209Not Applicable

Effect of Ozone Oil After Non-surgical Periodontal Treatment

Unknown
NCT05812391Not Applicable

Impact of Full Mouth Erythritol Powder Air Polishing on Systemic Inflammatory Response

Unknown
NCT05808569

Evaluating Breast Cancer Patients Modesty During Radiotherapy. A Multicentric Study

Completed
NCT03093610Not Applicable

Evaluation of Fluid Output Threshold for Safe Chest Tube Removal - A Potential Way to Decrease Length of Stay in Hospital and to Improve Postoperative Care After Lung Surgery?

Completed
NCT05413954Not Applicable

To Evaluate the Health Effect of Particular Fatty Acids Profiles From Eggs

Completed
NCT04631497

Assessment of Stress, Depression and Anxiety in Healthcare Caring for Patients With COVID-19

Completed
NCT05244850

The Relationship of Trunk Control With Lower Extremity Sense, Balance and Gait in Stroke

Completed
NCT05244863

The Relationship of Muscle Strength With Functional Skills in Geriatric Individuals With Essential Tremor

Completed
NCT05194826Not Applicable

Using Fascia Lata Membrane Versus Connective Tissue Graft in Immediate Implants

Unknown
NCT05085587Phase 1

Bioequivalence Study of Fluticasone Propionate 250 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 250/50 Inhalation Powder/GSK in Healthy Volunteers

Unknown
NCT04928547

An Integrated System for the Assessment of Carotid Plaque Stability Based on the Artificial Intelligence

Unknown
NCT04746040Phase 1

A Bioequivalence Study Between Fluticasone Propionate 250 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 250/50 Inhalation Powder/GSK in Healthy Volunteers

Unknown
NCT04790838

Pooled Analysis FP_SX_250_50

Completed

Drug Details

Intervention Type
OTHER
Total Trials
28